SLC13A5 and progeroid syndrome: In conclusion, the above results indicate that restoring the proteostatic functions of the ER by inhibiting ATase1 and ATase2 downstream of AT-1 ameliorates the progeria-like phenotype of SLC13A5 sTg mice.